In clinical trials, diarrhea is a common side effect, occurring in approximately 30% of patients taking Wegovy (semaglutide 2.4 mg) and 19-23% of patients taking Zepbound (tirzepatide), according to FDA prescribing information
BPC-157 and KPV through compounded sources typically cost $190-280 monthly, while Thymosin Alpha-1 ranges $320-380
Generally, it's recommended to take it on an empty stomach for better absorption
Safety Profile and Toxicological Considerations Preclinical Safety Studies Comprehensive preclinical safety evaluations of BPC-157 demonstrate a remarkably favorable toxicological profile
Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
In the context of tirzepatide therapy, which strongly improves insulin sensitivity, this is unlikely to be a problem, but it is worth monitoring in individuals with diabetes or prediabetes